Lescol and Lescol XL (Fluvastatin) Novartis

News
Article

Statin indicated for reduction in the risk of recurrent cardiac events

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Taljat-stock@abode.com

Novartis to Offer Cosentyx to Cash Paying Patients at a 55% Discount

Denise Myshko
September 30th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
September 30th 2025
Podcast

Listen

Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes

Denise Myshko
September 30th 2025
Article

Read More

FDA Approves Extended Indication for Evkeeza

FDA Approves Extended Indication for Evkeeza

Logan Lutton
September 30th 2025
Article

Read More

Valeriya Zankovych-stock@adobe.com

AstraZeneca to Offer Airsupra Direct to Patient

Denise Myshko
September 30th 2025
Article

Read More

AbbVie Submits NDA for Parkinson’s Disease Drug, Tavapadon

AbbVie Submits NDA for Parkinson’s Disease Drug, Tavapadon

Logan Lutton
September 30th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.